Left to right_Allen Law, COO & Dr Su Wei Xin, Group Consultant of Stemcell First Group
Kuala Lumpur, April 09, 2025 — Stemcell First Group has launched a groundbreaking Multiple Cancer Early Detection (MCED) blood test, capable of identifying over 50 types of cancer, including breast, lung, and pancreatic, at their earliest stages—often years before symptoms.
Priced at RM3,888 (down from RM4,888), the test is now available at Masayo Clinic in Kuala Lumpur, SCF Clinic in Bangkok, and soon at Vanfo Hino Ambulatory Care Centre in Johor Bahru.
“Early detection is a right for all,” said COO Allen Law. The initiative aims to make cancer screening routine across Southeast Asia, improving survival rates.
Read More News on Business News Malaysia
Read More News on Business News Malaysia
EG Industries is accelerating beyond traditional EMS, leveraging AI networking demand, 1.6T development, network switches…
Sime Darby Property has introduced a RM1.25 billion fund aimed at investing in new economy…
Pos Malaysia has consolidated all its courier offerings under the Pos Laju brand to streamline…
Jati launches Jati Chom Chom, a rice puff snack, expanding into the snack market with…
Maxim marked Kaamatan and Gawai with free rides and exclusive postcards, helping festivalgoers travel conveniently…
Desa Kerayong Indah's long-awaited revival reaches a key milestone, with major infrastructure progress, renewed homebuyer…
This website uses cookies.